益丰新材料IPO：营收三连降背后的“财技”与治理隐忧

Core Viewpoint - Yifeng New Materials Co., Ltd. has submitted its prospectus to the Shenzhen Stock Exchange's ChiNext after withdrawing its application for the Sci-Tech Innovation Board four years ago, despite facing a decline in revenue over three consecutive years from 2022 to 2024 [1][2]. Company Background and Core Risks - Established in 2011, Yifeng New Materials specializes in the research, production, and sales of sulfides, with the actual controllers holding a combined 49.96% stake. However, the company faces two significant inherent risks: a fragile core business and a heavy reliance on related parties [3][5]. - The global market size for its core product, thiourea, is projected to be approximately 851 million yuan in 2024, indicating limited growth potential despite holding a 26% market share. The company has attempted to pivot to optical new materials, but this segment contributes less than 30% of total revenue, highlighting its dependence on a declining traditional market [5][6]. IPO Journey and Underwriter Relationships - Yifeng New Materials has faced challenges in its capital journey, having previously attempted an IPO on the Sci-Tech Innovation Board in November 2021, which ended in withdrawal. The current attempt on the ChiNext marks its second effort [7]. - The underwriting firm for this IPO is Zhongtai Securities, which has a long-standing relationship with the controlling shareholders, raising questions about the independence and diligence of the underwriting process [10]. Governance, Operations, and Business Issues - The company has a complex history of shareholding, with the actual controller previously using up to 35 named shareholders for shareholding representation, reflecting governance issues and a lack of transparency. Additionally, a suspicious low-price share transfer occurred just before the IPO, warranting regulatory scrutiny [11]. - Significant turnover in the core management team in 2023 coincided with a decline in revenue, raising concerns about the stability of the company's strategic direction and operational effectiveness [12]. - The reported increase in gross margin from 34.98% to 39.49% is attributed to the divestiture of low-margin auxiliary businesses rather than genuine improvements in core product competitiveness, casting doubt on the sustainability of this margin enhancement [13][14]. Financial Data and Anomalies - The latest financial data in the prospectus reveals several concerning details beyond revenue decline, indicating potential underlying issues with operational quality and financial health [15]. Historical Issues and Regulatory Concerns - The company's historical reliance on related-party transactions and shareholding complexities have cast a shadow over its current IPO efforts. Regulatory bodies have previously scrutinized the company's pricing and sales practices, particularly regarding its foreign sales revenue [16]. Conclusion - The situation surrounding Yifeng New Materials presents a complex picture of unresolved governance issues, declining business performance, and financial anomalies. Investors and regulators are encouraged to look beyond the company's claimed global market share and critically assess its governance, business sustainability, and the implications of its financial data [17].